These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 401191)

  • 1. In vivo and in vitro correlates of high and moderate potency anti-thymocyte globulin in humans.
    Millington GM; Thomas FT; Thomas JM; Mendez-Picon G; Lower RR; Lee HM
    Surg Forum; 1978; 29():369-71. PubMed ID: 401191
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunofluorescent assay of anti-human thymocyte globulin as a means of correlating "in vitro" and "in vivo" activity.
    Ablin RJ; Morrell RM
    Dev Biol Stand; 1974; 27():223-8. PubMed ID: 4618534
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of anti-thymocyte globulin (ATGAM), Part I.
    Gilbert C
    N C Med J; 1984 Nov; 45(11):737-9. PubMed ID: 6392893
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-thymocyte globulin overdosage--risk or potential benefit?
    Zlabinger GJ; Pohanka E; Doleschel W; Zielinski C; Wolf H; Kovarik J
    Am J Med; 1988 Feb; 84(2):369-70. PubMed ID: 3044074
    [No Abstract]   [Full Text] [Related]  

  • 5. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance of peripheral veins to antithymocyte globulin after heart transplantation.
    Cantarovich M; Latter DA
    J Heart Lung Transplant; 1994; 13(4):737. PubMed ID: 7947896
    [No Abstract]   [Full Text] [Related]  

  • 7. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 8. The high dose therapy of anti-human lymphoblast globulin in living related renal transplantation.
    Dohi K; Fukuda Y; Asahara T; Yahata H; Ono E; Takenaka M; Marubayashi S; Omotehara T; Tabe Y; Eto T
    Hiroshima J Med Sci; 1984 Jun; 33(2):223-31. PubMed ID: 6384144
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rabbit anti-human thymocyte globulin in cadaver kidney transplantation. Preliminary experiences.
    Groth CG; Lundgren G; Ringdén O; Berg B; Grimfors G; Bieber CP
    Scand J Urol Nephrol Suppl; 1981; 64():200-4. PubMed ID: 6755681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients.
    Valderrábano F; Anaya F; Robles NR; Jofré R
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):75-8. PubMed ID: 3051597
    [No Abstract]   [Full Text] [Related]  

  • 12. Primate model for the study of in vitro--in vivo immunologic monitoring correlates: studies of in vitro correlates of rejection in rhesus monkeys treated with clinical ATG.
    Williams EA; Scott JD; Thomas FT; Thomas JM
    Transplant Proc; 1978 Sep; 10(3):581-4. PubMed ID: 309672
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose ATGAM treatment sufficiently reduces total T-cell counts and remains clinically effective in prophylactic and anti-rejection protocols.
    Ekberg H; Källén R; Schatz H; Persson NH
    Transplant Proc; 1995 Dec; 27(6):3430-1. PubMed ID: 8540035
    [No Abstract]   [Full Text] [Related]  

  • 14. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 15. [T-cell oriented therapy concept in the treatment of rejection following liver transplantation].
    Kremer B; Henne-Bruns D; Kraemer-Hansen H; Harfmann P; Kuhlencordt R; Schröder S
    Helv Chir Acta; 1989 Dec; 56(4):521-5. PubMed ID: 2632478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients.
    Olausson M; Mjörnstedt L; Blohmé I
    Transplant Proc; 1995 Dec; 27(6):3434-5. PubMed ID: 8540037
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro estimates of biological potency of equine antihuman thymocyte globulin (ATGAM).
    Nail SL; Bare JL; Bowes LG; Dumble LJ; Clunie GJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):968-9. PubMed ID: 2523155
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.
    Rodt H; Kolb HJ; Netzel B; Haas RJ; Wilms K; Götze CB; Link H; Thierfelder S
    Transplant Proc; 1981 Mar; 13(1 Pt 1):257-61. PubMed ID: 7022835
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.